Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Pfizer Inc. - La Jolla laboratories

Femme et Homme Max 99 ans
Pfizer Inc. - La Jolla laboratories MAJ Il y a 4 ans

A randomized phase 2 study of the anti-angiogenesis agent AG-013736 in combination with gemcitabine in patients with chemotherapy-naïve advanced pancreatic cancer preceded by a phase 1 portion Determine whether the overall survival of the combination of AG-013736 and gemcitabine is superior to that of gemcitabine alone in patients who have advanced pancreatic cancer that has not been previo...

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations